These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 526393)

  • 1. Labetalol in the treatment of patients with hypertension and renal function impairment.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
    [No Abstract]   [Full Text] [Related]  

  • 2. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
    Innes A; Gemmell HG; Smith FW; Edward N; Catto GR
    J Hum Hypertens; 1992 Jun; 6(3):211-4. PubMed ID: 1629891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of hypertension with labetalol.
    Erichs M; Rothgardt NP; Andersson E
    Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetolol in patients with hypertension and varying degrees of renal impairment.
    Breen EG; Lombard M; Watson A; Keogh JA
    Ir J Med Sci; 1984 Oct; 153(10):336-42. PubMed ID: 6511284
    [No Abstract]   [Full Text] [Related]  

  • 9. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre open trial of labetalol in New Zealand.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):179S-182S. PubMed ID: 393287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term study of labetalol in general practice.
    Kane J; Gregg I; Stephens MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):167S-170S. PubMed ID: 118766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Labetolol in the therapy of secondary arterial hypertension. A polycentric study].
    Palla R; Giusti R; Marchitiello M; Menicucci R
    Minerva Nefrol; 1982; 29(2):105-10. PubMed ID: 7133539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.